Determination of conformational changes in the progesterone receptor using ELISA-like assays

Steroids

Volumn 71, Issue 9, 2006, Pages 792-798

  Pullen, Mark A ^a   Laping, Nicholas ^a   Edwards, Richard ^a   Bray, Jeffrey ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

Conformation; ELISA; Progesterone receptor; Steroid

Indexed keywords

ALKALINE PHOSPHATASE; ANTIGESTAGEN; LIGAND; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MODULATOR; PROTEIN ANTIBODY;

AGONIST; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PROTEIN CONFORMATION; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; SCREENING;

ANIMALS; BINDING, COMPETITIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRENES; FEMALE; MIFEPRISTONE; OXIMES; PROTEIN BINDING; PROTEIN CONFORMATION; RABBITS; RECEPTORS, PROGESTERONE; STRUCTURE-ACTIVITY RELATIONSHIP; UTERUS;

EID: 33745934293     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.05.009     Document Type: Article

References (23)

1. Allan G.F., Leng X., Tsai S.Y., Weigel N.L., Edwards D.P., Tsai M.J., et al. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J Biol Chem 267 (1992) 19513-19520
2. Weigel N.L., Beck C.A., Estes P.A., Prendergast P., Altmann M., Christensen K., et al. Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. Mol Endocrinol 6 (1992) 1585-1597
3. Allan G.F., Lombardi E., Haynes-Johnson D., Palmer S., Kiddoe M., Kraft P., et al. Induction of a novel conformation in the progesterone receptor by ZK299 involves a defined region of the carboxyl-terminal tail. Mol Endocrinol 10 (1996) 1206-1213
4. Wagner B.L., Pollio G., Leonhardt S., Wani M.C., Lee D.Y., Imhof M.O., et al. 16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. Proc Natl Acad Sci USA 93 (1996) 8739-8744
5. DeMarzo A.M., Onate S.A., Nordeen S.K., and Edwards D.P. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor. Biochemistry 31 (1992) 10491-10501
6. Gass E.K., Leonhardt S.A., Nordeen S.K., and Edwards D.P. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation. Endocrinology 139 (1998) 1905-1919
7. Allan G.F., Tsai S.Y., Tsai M.J., and O'Malley B.W. Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding. Proc Natl Acad Sci USA 89 (1992) 11750-11754
8. Tetel M.J., Jung S., Carbajo P., Ladtkow T., Skafar D.F., and Edwards D.P. Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor. Mol Endocrinol 11 (1997) 1114-1128
9. Loosfelt H., Atger M., Misrahi M., Guiochon-Mantel A., Meriel C., Logeat F., et al. Cloning and sequence analysis of rabbit progesterone-receptor complementary DNA. Proc Natl Acad Sci USA 83 (1986) 9045-9049
10. Traish A.M., and Netsuwan N. 7 alpha-17 alpha-dimethyl-19-nortestosterone (mibolerone) induces conformational changes in progesterone receptors distinct from those induced by ORG. Steroids 59 (1994) 362-370
11. Edwards D.P., Leonhardt S.A., and Gass-Handel E. Novel mechanisms of progesterone antagonists and progesterone receptor. J Soc Gynecol Investig 7 (2000) S22-S24
12. Leonhardt S.A., and Edwards D.P. Mechanism of action of progesterone antagonists. Exp Biol Med 227 (2002) 969-980
13. Bain D.L., Franden M.A., McManaman J.L., Takimoto G.S., and Horowitz K.B. The N-terminal region of the human progesterone A-receptor. J Biol Chem 275 (2000) 7313-7320
14. Markiewicz L., and Gurpide E. Estrogenic and progestagenic activities coexisting in steroidal drugs: quantitative evaluation by in vitro bioassays with human cells. J Steroid Biochem Mol Biol 48 (1994) 89-94
15. Elger W., Bartley J., Schneider B., Kaufmann G., Schubert G., and Chwalisz K. Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity. Steroids 65 (2000) 713-723
16. Zhang P., Terefenko E.A., Fensome A., Wrobel J., Winneker R., Lundeen S., et al. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists. J Med Chem 45 (2002) 4379-4382
17. x and competitive drug antagonism. Br J Pharmacol 4 (1947) 277-280
18. Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., and O'Malley B.W. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc Natl Acad Sci USA 93 (1996) 12195-12199
19. DeManno D., Elger W., Garg R., Lee R., Schneider B., Hess-Stumpp H., et al. Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy. Steroids 68 (2003) 1019-1032
20. Liu Z., Auboeuf D., Wong J., Chen J.D., Tsai S.Y., Tsai M.J., et al. Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486. Proc Natl Acad Sci USA 99 (2002) 7940-7944
21. Vegeto E., Allan G.F., Schrader W.T., Tsai M.J., McDonnell D.P., and O'Malley B.W. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69 (1992) 703-713
22. Edwards D.P., Altmann M., DeMarzo A., Zhang Y., Weigel N.L., and Beck C.A. Progesterone receptor and the mechanism of action of progesterone antagonists. J Steroid Biochem Mol Biol 53 (1995) 449-458
23. Leonhardt S.A., Altmann M., and Edwards D.P. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. Mol Endocrinol 12 (1998) 1914-1930